CCNDBP1

Across TCGA pan-cancer cohorts, CCNDBP1 mass-spec protein is linked to patient survival in 4 of 34 cancer types, making it a survival-associated CCNDBP1 data layer compared with 23 for mass-spec protein and 3 for mutation status.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where higher CCNDBP1 mass-spec protein is associated with better overall survival. In most high-consensus cancer types, elevated CCNDBP1 expression acts as an unfavorable survival marker, although some lineages such as HNSC show a favorable association.

HNSC, CCRCC, and LUAD are the cancer types where CCNDBP1 mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
HNSC	OS	Tertile	II,III,IV	0.946	0.783	.010	20	view →
CCRCC	DFS	Quartile	III,IV	0.297	0.802	.003	11	view →
LUAD	OS	Tertile	II,III,IV	0.408	0.809	.019	8	view →
GBM	DFS	Tertile	All	0.623	0.821	.018	5	view →

Pink = unfavorable, green = favorable. Showing the 4 strongest of 4 lineages.

CCNDBP1–HNSC (OS)

Open the HNSC breakdown →